The University of Chicago Header Logo

Connection

Chang Sun to Powders

Back to Details
This is a "connection" page, showing publications Chang Sun has written about Powders.
Chang Sun
Connection Strength
13.463
Powders
  1. A material-sparing simplified buoyancy method for determining the true density of solids. Int J Pharm. 2023 Mar 25; 635:122694.
    View in: PubMed
    Score: 0.854
  2. A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets. Int J Pharm. 2020 Jul 30; 585:119517.
    View in: PubMed
    Score: 0.710
  3. Toward a Molecular Understanding of the Impact of Crystal Size and Shape on Punch Sticking. Mol Pharm. 2020 04 06; 17(4):1148-1158.
    View in: PubMed
    Score: 0.697
  4. Computational Techniques for Predicting Mechanical Properties of Organic Crystals: A Systematic Evaluation. Mol Pharm. 2019 04 01; 16(4):1732-1741.
    View in: PubMed
    Score: 0.652
  5. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression. J Pharm Sci. 2018 04; 107(4):968-974.
    View in: PubMed
    Score: 0.597
  6. The suitability of common compressibility equations for characterizing plasticity of diverse powders. Int J Pharm. 2017 Oct 30; 532(1):124-130.
    View in: PubMed
    Score: 0.585
  7. Profoundly improving flow properties of a cohesive cellulose powder by surface coating with nano-silica through comilling. J Pharm Sci. 2011 Nov; 100(11):4943-52.
    View in: PubMed
    Score: 0.381
  8. Massing in high shear wet granulation can simultaneously improve powder flow and deteriorate powder compaction: a double-edged sword. Eur J Pharm Sci. 2011 May 18; 43(1-2):50-6.
    View in: PubMed
    Score: 0.376
  9. Roles of granule size in over-granulation during high shear wet granulation. J Pharm Sci. 2010 Aug; 99(8):3322-5.
    View in: PubMed
    Score: 0.358
  10. Development of a high drug load tablet formulation based on assessment of powder manufacturability: moving towards quality by design. J Pharm Sci. 2009 Jan; 98(1):239-47.
    View in: PubMed
    Score: 0.321
  11. Quantifying effects of particulate properties on powder flow properties using a ring shear tester. J Pharm Sci. 2008 Sep; 97(9):4030-9.
    View in: PubMed
    Score: 0.314
  12. On the mechanism of reduced tabletability of granules prepared by roller compaction. Int J Pharm. 2008 Jan 22; 347(1-2):171-2; author reply 173-4.
    View in: PubMed
    Score: 0.295
  13. A novel method for deriving true density of pharmaceutical solids including hydrates and water-containing powders. J Pharm Sci. 2004 Mar; 93(3):646-53.
    View in: PubMed
    Score: 0.230
  14. A new insight into the mechanism of the tabletability flip phenomenon. Int J Pharm. 2024 Apr 10; 654:123956.
    View in: PubMed
    Score: 0.230
  15. The ubiquity of the tabletability flip phenomenon. Int J Pharm. 2023 Aug 25; 643:123262.
    View in: PubMed
    Score: 0.220
  16. Modulating Pharmaceutical Properties of Berberine Chloride through Cocrystallization with Benzendiol Isomers. Pharm Res. 2023 Dec; 40(12):2791-2800.
    View in: PubMed
    Score: 0.218
  17. An approach for predicting the true density of powders based on in-die compression data. Int J Pharm. 2023 Apr 25; 637:122875.
    View in: PubMed
    Score: 0.215
  18. An extended macroindentation method for determining the hardness of poorly compressible materials. Int J Pharm. 2022 Aug 25; 624:122054.
    View in: PubMed
    Score: 0.206
  19. Effect of deaeration on processability of poorly flowing powders by roller compaction. Int J Pharm. 2022 Jun 10; 621:121803.
    View in: PubMed
    Score: 0.202
  20. Air entrapment during tablet compression - Diagnosis, impact on tableting performance, and mitigation strategies. Int J Pharm. 2022 Mar 05; 615:121514.
    View in: PubMed
    Score: 0.199
  21. Efficient development of sorafenib tablets with improved oral bioavailability enabled by coprecipitated amorphous solid dispersion. Int J Pharm. 2021 Dec 15; 610:121216.
    View in: PubMed
    Score: 0.195
  22. Modulation of the powder properties of lamotrigine by crystal forms. Int J Pharm. 2021 Feb 15; 595:120274.
    View in: PubMed
    Score: 0.185
  23. Development of piroxicam mini-tablets enabled by spherical cocrystallization. Int J Pharm. 2020 Nov 30; 590:119953.
    View in: PubMed
    Score: 0.182
  24. Profound tabletability deterioration of microcrystalline cellulose by magnesium stearate. Int J Pharm. 2020 Nov 30; 590:119927.
    View in: PubMed
    Score: 0.181
  25. Tabletability Flip - Role of Bonding Area and Bonding Strength Interplay. J Pharm Sci. 2020 12; 109(12):3569-3573.
    View in: PubMed
    Score: 0.181
  26. The efficient development of a sildenafil orally disintegrating tablet using a material sparing and expedited approach. Int J Pharm. 2020 Nov 15; 589:119816.
    View in: PubMed
    Score: 0.180
  27. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach. Pharm Res. 2020 Jul 23; 37(8):153.
    View in: PubMed
    Score: 0.179
  28. Molecular Origin of the Distinct Tabletability of Loratadine and Desloratadine: Role of the Bonding Area - Bonding Strength Interplay. Pharm Res. 2020 Jun 28; 37(7):133.
    View in: PubMed
    Score: 0.178
  29. Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods. Int J Pharm. 2020 Jan 25; 574:118914.
    View in: PubMed
    Score: 0.171
  30. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer. Pharm Res. 2019 Apr 23; 36(6):90.
    View in: PubMed
    Score: 0.164
  31. Direct Compression Tablet Containing 99% Active Ingredient-A Tale of Spherical Crystallization. J Pharm Sci. 2019 04; 108(4):1396-1400.
    View in: PubMed
    Score: 0.159
  32. Comparative analyses of flow and compaction properties of diverse mannitol and lactose grades. Int J Pharm. 2018 Jul 30; 546(1-2):39-49.
    View in: PubMed
    Score: 0.153
  33. Modulating Sticking Propensity of Pharmaceuticals Through Excipient Selection in a Direct Compression Tablet Formulation. Pharm Res. 2018 Mar 30; 35(6):113.
    View in: PubMed
    Score: 0.152
  34. Systematic evaluation of common lubricants for optimal use in tablet formulation. Eur J Pharm Sci. 2018 May 30; 117:118-127.
    View in: PubMed
    Score: 0.151
  35. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer. Pharm Res. 2017 12 29; 35(1):4.
    View in: PubMed
    Score: 0.150
  36. Ribbon thickness influences fine generation during dry granulation. Int J Pharm. 2017 Aug 30; 529(1-2):87-88.
    View in: PubMed
    Score: 0.144
  37. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression. J Pharm Sci. 2017 07; 106(7):1772-1777.
    View in: PubMed
    Score: 0.142
  38. Powder properties and compaction parameters that influence punch sticking propensity of pharmaceuticals. Int J Pharm. 2017 Apr 15; 521(1-2):374-383.
    View in: PubMed
    Score: 0.141
  39. Mechanism and Kinetics of Punch Sticking of Pharmaceuticals. J Pharm Sci. 2017 01; 106(1):151-158.
    View in: PubMed
    Score: 0.137
  40. Microstructure of Tablet-Pharmaceutical Significance, Assessment, and Engineering. Pharm Res. 2017 05; 34(5):918-928.
    View in: PubMed
    Score: 0.135
  41. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression. J Pharm Biomed Anal. 2016 Sep 05; 128:462-468.
    View in: PubMed
    Score: 0.134
  42. Macroindentation hardness measurement-Modernization and applications. Int J Pharm. 2016 Jun 15; 506(1-2):262-7.
    View in: PubMed
    Score: 0.133
  43. A critical Examination of the Phenomenon of Bonding Area - Bonding Strength Interplay in Powder Tableting. Pharm Res. 2016 May; 33(5):1126-32.
    View in: PubMed
    Score: 0.131
  44. Dependence of tablet brittleness on tensile strength and porosity. Int J Pharm. 2015 Sep 30; 493(1-2):208-13.
    View in: PubMed
    Score: 0.127
  45. A new tablet brittleness index. Eur J Pharm Biopharm. 2015 Jun; 93:260-6.
    View in: PubMed
    Score: 0.124
  46. Evolution of structure and properties of granules containing microcrystalline cellulose and polyvinylpyrrolidone during high-shear wet granulation. J Pharm Sci. 2014 Jan; 103(1):207-15.
    View in: PubMed
    Score: 0.112
  47. A pitfall in analyzing powder compactibility data using nonlinear regression. J Pharm Sci. 2013 Mar; 102(3):1135-6.
    View in: PubMed
    Score: 0.106
  48. Preparation and characterization of surface-engineered coarse microcrystalline cellulose through dry coating with silica nanoparticles. J Pharm Sci. 2012 Nov; 101(11):4258-66.
    View in: PubMed
    Score: 0.103
  49. Probing interfaces between pharmaceutical crystals and polymers by neutron reflectometry. Mol Pharm. 2012 Jul 02; 9(7):1953-61.
    View in: PubMed
    Score: 0.102
  50. Origin of two modes of non-isothermal crystallization of glasses produced by milling. Pharm Res. 2012 Apr; 29(4):1020-32.
    View in: PubMed
    Score: 0.099
  51. Overcoming poor tabletability of pharmaceutical crystals by surface modification. Pharm Res. 2011 Dec; 28(12):3248-55.
    View in: PubMed
    Score: 0.095
  52. Initial moisture content in raw material can profoundly influence high shear wet granulation process. Int J Pharm. 2011 Sep 15; 416(1):43-8.
    View in: PubMed
    Score: 0.095
  53. Transforming powder mechanical properties by core/shell structure: compressible sand. J Pharm Sci. 2010 Nov; 99(11):4458-62.
    View in: PubMed
    Score: 0.091
  54. Materials science tetrahedron--a useful tool for pharmaceutical research and development. J Pharm Sci. 2009 May; 98(5):1671-87.
    View in: PubMed
    Score: 0.082
  55. Improving powder flow properties of citric acid by crystal hydration. J Pharm Sci. 2009 May; 98(5):1744-9.
    View in: PubMed
    Score: 0.082
  56. Influence of crystal structure on the tableting properties of n-alkyl 4-hydroxybenzoate esters (parabens). J Pharm Sci. 2007 Dec; 96(12):3324-33.
    View in: PubMed
    Score: 0.074
  57. Thermal expansion of organic crystals and precision of calculated crystal density: a survey of Cambridge Crystal Database. J Pharm Sci. 2007 May; 96(5):1043-52.
    View in: PubMed
    Score: 0.072
  58. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example. Int J Pharm. 2006 Dec 01; 326(1-2):94-9.
    View in: PubMed
    Score: 0.068
  59. True density of microcrystalline cellulose. J Pharm Sci. 2005 Oct; 94(10):2132-4.
    View in: PubMed
    Score: 0.064
  60. Quantifying errors in tableting data analysis using the Ryshkewitch equation due to inaccurate true density. J Pharm Sci. 2005 Sep; 94(9):2061-8.
    View in: PubMed
    Score: 0.064
  61. Effect of Lipidic Excipients on the Particle Properties and Aerosol Performance of High Drug Load Spray Dried Particles for Inhalation. J Pharm Sci. 2022 04; 111(4):1152-1163.
    View in: PubMed
    Score: 0.048
  62. Molecular Interpretation of the Compaction Performance and Mechanical Properties of Caffeine Cocrystals: A Polymorphic Study. Mol Pharm. 2020 01 06; 17(1):21-31.
    View in: PubMed
    Score: 0.043
  63. The role of the screw profile on granular structure and mixing efficiency of a high-dose hydrophobic drug formulation during twin screw wet granulation. Int J Pharm. 2020 Feb 15; 575:118958.
    View in: PubMed
    Score: 0.043
  64. Expedited Investigation of Powder Caking Aided by Rapid 3D Prototyping of Testing Devices. J Pharm Sci. 2020 01; 109(1):769-774.
    View in: PubMed
    Score: 0.042
  65. Effects of Water on Powder Flowability of Diverse Powders Assessed by Complimentary Techniques. J Pharm Sci. 2019 08; 108(8):2613-2620.
    View in: PubMed
    Score: 0.041
  66. Developing Biologics Tablets: The Effects of Compression on the Structure and Stability of Bovine Serum Albumin and Lysozyme. Mol Pharm. 2019 03 04; 16(3):1119-1131.
    View in: PubMed
    Score: 0.041
  67. Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin. Mol Pharm. 2019 03 04; 16(3):1305-1311.
    View in: PubMed
    Score: 0.040
  68. Near-infrared chemical imaging (NIR-CI) as a process monitoring solution for a production line of roll compaction and tableting. Eur J Pharm Biopharm. 2015 Jun; 93:293-302.
    View in: PubMed
    Score: 0.031
  69. [Research about improving flowability of powder of Chinese herbs extracts by surface modification technology]. Zhongguo Zhong Yao Za Zhi. 2014 Dec; 39(23):4590-5.
    View in: PubMed
    Score: 0.030
  70. The manufacture of low-dose oral solid dosage form to support early clinical studies using an automated micro-filing system. AAPS PharmSciTech. 2011 Mar; 12(1):88-95.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.